Clincosm LogoSign in Get a demo

carcinomas

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Carcinomas, Cervix Cancer, Cervical Cancer Trial in Houston (AK104)

Recruiting
  • Carcinomas
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

Not yet recruiting
  • Carcinomas
  • Renal Medullary Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 20, 2022

School Response to Families Who Have Children With Cancer

Withdrawn
  • Carcinomas
  • +2 more
  • Self administered Surveys
  • Interviews
  • Stanford, California
    Stanford University School of Medicine
Jun 22, 2017

B-Receptor Signaling in Cardiomyopathy

Completed
  • Carcinomas
  • +37 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 16, 2015

    Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (brentuximab vedotin, rifampin, midazolam)

    Completed
    • Carcinomas
    • +4 more
    • brentuximab vedotin
    • +3 more
    • Duarte, California
    • +5 more
    Dec 17, 2014

    Symptom Assessment With Patient Surveys

    Completed
    • Carcinomas
    • +2 more
    • Patient survey
    • Stanford, California
      Stanford University School of Medicine
    Jun 2, 2010

    Carcinomas Trial in Villejuif (Escitalopram)

    Unknown status
    • Carcinomas
    • Villejuif, France
      Institut Gustave Roussy
    Sep 1, 2009